COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan

White House Domestic Policy Council Director Joe Grogan is departing at the end of May. In an interview, he talked about lessons (so far) from the COVID-19 response and the future of drug pricing policy against the backdrop of the pandemic.

White house in Washington DC (USA)

More from Pricing Debate

More from Market Access